Sekėjai

Ieškoti šiame dienoraštyje

2026 m. balandžio 7 d., antradienis

‘Ozempic for Baldness’ Is Changing the Way Men See Themselves

“For most of his 20s, Elliot Connors did not think a lot about his hair. He was losing some of it, maybe — but so what? This was what happened to men. He was funny and sharp; he had a girlfriend.

 

He began to worry only after he and some friends from graduate school in New York started a group chat last summer. In it, they talked about their classes and sports and joked about their love lives, and the thread frequently digressed into a series of semiserious conversations about hair loss: whether their hairlines were staying the same or, God forbid, receding; which products to apply, which medications to take; how much they did or didn’t care.

 

Several of Connors’s friends were taking a drug called finasteride, which is remarkably effective — the research shows that it significantly slows hair loss in most men for at least 10 years (with many men reporting effectiveness well beyond that); studies have found that it stimulates at least some renewed hair growth in a majority of men.

 

Connors’s friends kept close track of their progress from week to week. Dermatologists commonly recognize seven stages of hair loss, which were refined and popularized in the 1970s by O’Tar Norwood, a dermatologist and pioneer of hair transplant surgery. Many of Connors’s friends, young men in their 20s, were a Norwood 2 or even a Norwood 3, displaying the beginnings of a creeping V on both sides of the forehead. (When you reach a Norwood 6, you may be “cooked,” in the online discourse of hair loss: too far gone for help.)

 

Before too long, Connors began inspecting his hands after washing his hair. Was more of it falling out than usual? He examined old photos of himself and compared them with his reflection in the mirror, looking for signs of change. He grew increasingly observant of other men’s hair: He noticed whose hairline was receding, and who was so young that he took his lush mane for granted, blissfully ignorant of the hair loss that was most likely in his future. He started to think he had no choice if he wanted to keep up: He’d better start taking finasteride.

 

He had read that finasteride could cause worrisome side effects — low libido, for example, or depression — and he would come to feel conflicted about the popularity of the drug. “We could all just not be on any of this stuff, and then our relative appearances would be the same,” he said. “But now we all have to be on it just to keep up with everyone else who’s on it. It’s like a nuclear arms race.”

 

Losing your hair, for men, was once largely inevitable and nearly universal.

 

Two-thirds of American men will experience hair thinning by their mid-30s, and 85 percent will experience significant hair loss by 50, according to the American Hair Loss Association.

 

“People used to say, ‘Losing your hair is just part of life — accept it,’” said Marc Avram, a dermatologist in New York who specializes in treating hair loss. In earlier eras, Hollywood’s leading men — Paul Newman, Jack Nicholson, Bruce Willis — played romantic leads long after their hairlines started to recede. Fathers and uncles counseled the young men in their lives to come to terms with the changes as part of the journey into adulthood. “There was literally no other option,” Avram said, “other than plugs.”

 

Today that’s no longer true. Celebrities and others who can afford it shell out up to $20,000 to get hair transplants, which have become harder to detect and ever more precise. Surgeons can now extract individual healthy follicles from abundant areas of their patients’ heads and implant them, one by one, into the scalps’ hair deserts. This more expensive, newer approach promises a more natural hairline, although those who know what to look for can still tell when someone has had the procedure. “If an actor has a full head of hair sticking straight up from his forehead and he’s over 30, he’s probably had one,” said Leah Ansell, a dermatologist in Rye, N.Y., who says she likes to point them out to her husband during awards shows. “They’ve all had one. All of them.”

 

Men with more modest means can find packages that fly them to Turkey and deliver the same procedure for around $3,000 — or they can start with the cheapest option of all, which is going on finasteride.

 

Prescriptions for the drug in the United States tripled between 2017 and 2024, a time when telehealth companies were taking off, just as men started spending hours a day staring at their hairlines on Zoom.

 

Feeding that anxiety is a mass-marketing campaign teaching men the same brutal self-scrutiny that women have long been trained to perform. A typical male in his 20s or 30s is likely to receive a flood of ads and shout-outs on Instagram, TikTok, YouTube and the livestreaming platform Twitch for hair-growth products that appeal to men their age: not just the usual tablets but chewable pills and sleek black bottles of “Mane Spray.”

 

Young men have also been encouraged to care deeply about their appearance by their country’s own commander in chief, whose highest praise for various appointees includes comments about their good looks. He’s “central casting,” President Trump said of his new pick for the chair of the Federal Reserve, Kevin Warsh — a man in his 50s, it must be noted, who has a full head of hair. (Pete Hegseth, the secretary of defense, is more like a Norwood 2.) Trump seems to have a particular obsession with hair, talking at one campaign rally about all the best products he douses his head with in the shower, and famously asking a young woman at another event to come up and inspect his hair to verify that it was all his own (and not, as one radio personality was suggesting, a toupee).

 

Young men who have come of age in the time of the manosphere are prime audiences for endless reels from influencers — some of them exceptionally buff, some of them funny, some of them with millions of followers — who are trying various treatments in the hope of regaining a full head of hair. The hair-loss influencer (it’s a category unto itself) Zeph Sanders has over one million TikTok followers tracking his “hair journey.” Typical content: “POV: You spent the last year falling in love with yourself,” reads the text introducing a quick montage of all the steps he has taken over the past 12 months to improve his hair (starting with a hair transplant). The ubiquity of this kind of content makes losing one’s hair no longer seem inevitable; going bald can now feel like a choice — a conscious decision.

 

Frequently the advertising and those influencers are conveying the message to young men that they should start taking finasteride young — in their early 20s — so that they don’t lose their hair in the first place. Andrew Dudum, a co-founder of Hims & Hers, one of the main telehealth companies selling hair-loss medication, said in a 2017 interview that their goal was to market those treatments to a younger audience, adding that while he was in his college, he and his friends could have benefited from products that protected their hairlines. The approach fits into the broader “prejuvenation” trend, in which young men and women are using lasers, fillers and products like Botox to fend off signs of aging before they start, rather than doing damage control when degradation is already well underway.

 

Ansell, the dermatologist, said she has had parents come in asking about finasteride for their teenage sons, looking to make sure they get “all the best they can have in order to succeed in life.” Young men are also coming in on their own for help keeping their hair. “More of them are really anxious about it,” Ansell said. “There’s no new epidemic of hair loss, but there is an epidemic of men freaking out about it.”

 

Before there was finasteride, there was rosemary oil, there was sunlight-exposure therapy, there were hair plugs, there were comb-overs, there were toupees. Before there was hair-loss medication prescribed by online pharmacies in elegantly designed, minimalist, earth-toned packaging, there was the exclusive-sounding Hair Club for Men, a business created by Sy Sperling, a former pool salesman who collaborated with a hair stylist to offer weaves that blended a man’s own remaining hair with color-matched hair on a nylon mesh. “I’m not only the Hair Club president,” Sperling says in a commercial from 1984, displaying a full head of chestnut brown hair, “but I’m also a client.”

 

In the 1970s, doctors studying minoxidil for its effects on blood pressure noticed in early trials that it caused men’s hair to grow. It was later brought to market for hair loss under the name Rogaine. The drug, which seems to make it easier for blood, oxygen and nutrients to reach hair follicle cells, has been wildly popular ever since, but only in about half of men will minoxidil trigger the kind of enzyme activity required for the drug to be effective. A majority of men who use it do find that it thickens their hair and slows the hair-loss process — but it seems to delay hair loss, not prevent it altogether.

 

Finasteride, by contrast, tends to yield better results for men hoping to hold on to their hair and to promote new growth. Researchers first noticed its effects on hair in the early ’90s, when the drug was being administered in a trial to treat men with enlarged prostates. The drug inhibits the conversion of testosterone into a hormone known as DHT, which is crucial in the development of male characteristics. In adult men, DHT is also associated with hair growth on their bodies and hair loss on their heads. Why hair follicles respond to DHT so differently depending on where they are on the body is one of the hormone’s mysteries. Doctors don’t even understand why men tend to lose the hair above their temples first, but they do know that finasteride is especially effective in bringing back hair on the top and toward the back of the head. Once an area of the scalp is shiny smooth, that means that the hair follicles in that area may be too shriveled to be revitalized.

 

First brought to market for hair loss by Merck as Propecia in 1997, the pill became available in generic form in 2013. By the time the pandemic hit and telemedicine took off, it was already cheap; now men could access it privately, in some states, simply by uploading a few photos and answering a few questions online. Also available at big-box-store pharmacies for as little as $5 a month — less than the cost of a single day’s latte fix — the drug is nonetheless a lifelong commitment, at least for men who continue to care about their hairlines. When men go off the drug, their hair loss resumes in about six months.

 

Finasteride, many dermatologists think, is one of the great cosmetic cures of the 20th century. And yet there is a catch: As many as one in 20 men who take the drug orally will experience a side effect — erectile dysfunction, low libido or, occasionally, low sperm count or depression. A vast majority of the time, those symptoms resolve in a few weeks after men go off finasteride (and sometimes even when they stay on it), according to studies of the drug.

 

But in rare instances, men have reported debilitating symptoms that continue even after they stop taking the drug. In addition to erectile dysfunction, low libido and depression, some men have also reported symptoms such as genital numbness, cognitive difficulties, a shrinking of the penis and even suicidal ideation. Having one or more of these ongoing symptoms is known among some researchers and patients as post-finasteride syndrome, which is poorly understood and a topic of considerable debate in the field.

 

Well-conducted research from a randomized controlled study published in 2021 found that using finasteride topically — applying a spray or a gel on the head — reduces the likelihood of serious side effects and is almost as effective as the oral version.

 

And new drugs, including one that stimulates hair follicles’ mitochondria, are expected to come on the market in the next few years and reportedly have no side effects.

 

But for now, most dermatologists still prescribe oral finasteride, which has been studied the longest.

 

Topical versions, which are still not approved by the F.D.A., typically cost more and have to come from a compounding pharmacy. Many men also grow frustrated with regularly applying serums or gels because the products mat their hair during the day or leave their pillow greasy at night. Doctors worry about finasteride coming into close contact with women who are pregnant (or may become pregnant), given that DHT plays a significant role in a developing male fetus.

 

And although finasteride itself won’t cause hair growth on, say, a girlfriend’s cheek, it’s often compounded with minoxidil, which might.

 

“I, for one, would never take the medication,” said Jonathan Clavell, a urologist in Houston. “Because if I were one of the unlucky few who turns out to get the syndrome, I know I’d regret it.” While the dermatologists I spoke with said they’ve never seen a patient who suffered from ongoing symptoms, Clavell is one of five urologists I interviewed who said they had. He even suspects that the number of people reporting those serious problems could be artificially low, because so many men secretly suffer in shame with erectile dysfunction and never seek a diagnosis or help. And men suffering from depression or brain fog might not make the connection — Clavell has seen some patients who have no idea, until he asks them for a list of the drugs they’ve taken, that finasteride might be associated with those symptoms.

 

Clavell has tremendous sympathy for his patients — earlier in his 40s, he himself was a quickly balding man who was tempted to do anything he could to keep his hair (for years he relied on minoxidil, which eventually stopped working). “I believe there’s a very big misconception that only women care about their appearance,” he said. “And it’s not true. Men just don’t talk about it with our friends. But secretly, behind closed doors, we are trying to keep our younger selves for as long as we can.” Maybe it is some kind of machismo, he mused, that makes men so likely to compare their own hair with others’. “When you watch TV and movies and all these actors,” Clavell said, “they have beautiful, long hair. You’re like, ‘Man, how are they able to keep all that volume?’”

 

Clavell’s wife, Mildred Lopez Pineiro, a dermatologist with a thriving practice in Houston, regularly prescribes finasteride once she’s alerted patients to the possible side effects. “If they’re informed and willing to take the risk, why not?” she said. But she has assured her husband that she does not feel as if he needs it and supports whatever choices he makes about his hair. Clavell recently gave up on salvaging it and shaved his head, as have many balding men, some of whom are active on dedicated forums or proudly serving as social media cheerleaders for the look. He has been at peace with his choice, even when his 5-year-old daughter commented on the change. “Daddy,” she said to him, “you don’t have hair anymore!”

 

The social media universe expends so much energy on the topic of male hair loss that meta conversations online can assume viewers’ familiarity with the obsession. “What would you rather lose: a finger or your hair?” the comedian Hannah Berner asked a series of men on her Instagram feed last December. “Finger,” answered her fellow comic Erik Scott. “Fingers!” When the comedian Adam Friedland filmed an episode of his show with the influencer Clavicular, a steroid-loving, status-chasing champion of a classically handsome aesthetic, he asked a question that made it clear how ubiquitous concerns are about finasteride’s side effects: Would you rather lose your hair or your penis? Friedland and Clavicular agreed: They’d want to keep their hair.

 

The dilemma over the drug’s trade-offs is a perennial topic of debate on one of the more popular men’s health subreddits on Reddit, r/tressless, a space where men have been discussing hair loss and treatment since 2011. The subreddit saw a huge spike in traffic during the pandemic and now has about 413,000 weekly visitors (roughly four times the number of weekly visitors to r/WegovyWeightLoss, for example, a popular subreddit devoted to that GLP-1). Men share pictures of triumphant hair regrowth, seek reassurance, pour out their hearts, vent their frustrations about the women who reject them and get into vicious debates about whether or not the drug actually poses a real risk. “Doctors tell me to avoid finasteride” is the name of one thread; “Finasteride changed my life for the better” starts another.

 

The discourse veers from admissions of profound insecurity to signs of real mental health struggles. “I hate hairloss to my core,” one poster wrote three months ago. “I’m literally gonna cry bro.” He couldn’t even lead a normal life, he wrote, with his hair thinning starting so young. Another man said going bald was so awful for him that he was wondering whether anyone else was reconsidering having children, given that hair loss is genetic.

 

After I posted a request on Reddit for men to share their thoughts about finasteride and hair loss, Kieran (his middle name), a project manager in London, reached out to me in the spirit of making a public service announcement: He worried that needless fears of rare side effects were keeping men from leading happier lives. He was so concerned about his hair loss, which started in his 20s, that his anxiety seemed akin to what experts call hair loss dysmorphic disorder. When he socialized, he always wore a cap; he was embarrassed when he met up with his old friends from high school because of the jokes they made about his skull. He became convinced that his social status had plummeted. He had a girlfriend, but he felt insecure in the relationship.

 

He started on finasteride and was seeing results — but the reports on Reddit unnerved him and he went off the drug for several years, until he felt his hair loss was intolerable enough that it was worth taking whatever small risk was involved. “My relationship got better because I felt so much more confident,” he told me. “I volunteer for things I never would have done. I’m competing in a CrossFit competition. I’m doing more public speaking at work.” He was convinced that men with more hair who look younger are treated differently. “People make quick judgment calls,” he said. “They might see someone whose hair is thinning and think they’re a stressed-out person who doesn’t look after themselves.”

 

Another man who responded to me was a 27-year-old lawyer in New Jersey who had also become somewhat obsessed with his balding crown. He felt shame about his hair, and maybe even more shame about how much he cared. “On a distress scale of 1 to 10, I was at about an 8,” he said. He found r/tressless and was unsure which worried him more: the stories of so many men who claimed that hair loss tanked their dating opportunities or the ones who said the drug tanked their sex lives. Finally, more persuaded by all the positive comments he was reading, he decided to go on the drug — and quickly observed a troubling change in his sex life: He was producing more watery semen, a rare but known side effect of the drug’s tendency to shrink the prostate. His erections were also not as hard.

 

From everything the lawyer read, his symptoms would resolve as soon as he stopped taking finasteride — which he knew some posters saw as an argument to persist, at least until he had a girlfriend. “But it felt weird to be taking a medication that would do that to me and somehow say, ‘That’s OK,’” he said. “I just felt like I couldn’t be sure that this wouldn’t somehow have long-lasting effects.” He went off the drug. The symptoms did quickly resolve, and he looks back at that period of misery as wasted energy. Now happily married, he responded to me to urge men to stay off the message boards. “They’re an echo chamber of anxiety,” he said.

 

One young man told me he first ordered finasteride from a telehealth platform when he was 23. He was new to a relationship and got nervous when he started experiencing sexual side effects. He went to another online provider and ordered a pill that treats erectile dysfunction, rather than lose more of his hair. Rachel Rubin, a urologist who specializes in sexual medicine in the Washington, D.C., area, told me that some patients who come to her for sexual problems refuse to go off finasteride, even after she has explained that the drug could well be causing or exacerbating the issue. It worries her that they prioritize their hair, even as their sex lives might suffer, making their search for intimacy that much harder.

 

Finasteride might be the ultimate drug for a generation of young men who have never been more focused on optimizing their looks — and yet have never been less connected, romantically or socially. Social media not only feeds men self-improvement content on their phones but also encourages them to curate images of themselves for others to scrutinize. Plenty of men in their 50s might be hard-pressed to find more than a few dozen photos of themselves from their 20s — but a typical 20-something guy might post that many in just a few months, putting himself out there to be appraised and judged.

 

Psychologists have known for years that women who are especially preoccupied with their physical appearance tend to have more difficulty with anxiety and sexual satisfaction. “Women have had this kind of thing to deal with for so many years,” said Ryan, one of the friends in Elliot Connors’s group chat. “While it’s awful that this is now happening to men, there is also a kind of a poetic justice to it.”

 

Connors and a few friends from the chat group had agreed to join me at a restaurant in SoHo in March to talk about their hairlines. Ryan, who asked to use only his first name so he could speak frankly about something so personal, described how he became fixated on his hair loss right after graduating from the University of California, Santa Barbara. The town was full of young students, who made him all the more self-conscious; at home during the pandemic, he had far too much time on his hands to watch social media and then stare at his receding hairline in the mirror. He had been taking finasteride since 2023 and was relieved by the volume he’d recaptured.

 

Ryan didn’t have any side effects from the medication, which Alex, a young man sitting next to him, was also taking. Only when I posed the question directly to the gathering did he mention that he, in fact, had experienced a dip in his sex drive when he went on the medication.

 

This was news to the group. “You didn’t text the group chat,” Connors said. “You have to tell us!”

 

Alex (who also asked that only his first name be used) defended himself — this was before the group chat started. At the time, he was unprepared for this possibility; the doctor who offered him the prescription did not mention anything about low libido. He went off as soon as he noticed — but then all the hair that had filled in started noticeably thinning. He decided he would try the drug once more. “If it happens again, then I’ll go off it for good,” he told himself. The second time around, he said, the issue seemed to resolve. He was relieved by how much his hair had filled in since then.

 

Connors himself started taking finasteride last fall. At first, he thought he’d made a mistake. He was rattled: He kept worrying about potential side effects he’d read about on Reddit. He couldn’t remember precisely if some depressive symptoms he started feeling had come on soon after he first took the drug — but to be safe, after a few weeks, he went off it. When his low mood persisted, he kept up a running joke with his friends: He definitely had post-finasteride syndrome! Then again, maybe he was just feeling depressed because he knew he was no longer helping his hairline.

 

Eventually, having chalked up that previous dark mood to a stressful time in his life rather than to the finasteride, he went back on the drug. He said he wouldn’t be surprised if at some point he returns to perseverating and second-guessing his decision, but for now, about three months into his second effort, he feels fine and is hopeful that he’s had some hair regrowth. Lately he’s even been thinking he should talk to his brother, who’s three years younger. Get started now, he’d tell him. Before it’s too late.” [1]

 

1. ‘Ozempic for Baldness’ Is Changing the Way Men See Themselves. Dominus, Susan.  New York Times (Online) New York Times Company. Apr 7, 2026.

„Nesuvaržytas tiesos“: Ronano Farrow gilus žvilgsnis į „OpenAI“ vadovą Samą Altmaną atskleidžia dirbtinio intelekto karaliaus sociopatines tendencijas

„Žurnalistai Ronanas Farrow ir Andrew Marantzas paskelbė tyrimą apie Samą Altmaną, dirbtinio intelekto karalių, stovintį už „OpenAI“, atskleisdami nerimą keliančią apgaulės ir sociopatinių polinkių istoriją. Vienas buvęs „OpenAI“ valdybos narys aiškina: „Jis turi dvi savybes, kurios beveik niekada nepastebimos tame pačiame asmenyje. Pirmasis yra stiprus noras įtikti žmonėms, būti mėgstamam bet kokioje sąveikoje. Antrasis yra beveik sociopatinis abejingumas pasekmėms, kurios gali kilti apgaudinėjant ką nors.“

 

„The New Yorker“ paskelbė išsamų Ronano Farrow ir Andrew Marantzo parašytą „OpenAI“ generalinio direktoriaus Samo Altmano tyrimą. Straipsnyje pateikiama įdomi ir nuodugniai ištirta Altmano gyvenimo apžvalga, įskaitant išsamias jo trumpalaikio pašalinimo iš įmonės detales.

 

Straipsnyje aiškinama, kad žymūs dirbtinio intelekto pasaulio veikėjai labai nepasitiki Altmanu, daugelis jo asmenybę apibūdina žodžiu „sociopatas“. Altmano priešų sąrašas neapsiriboja „OpenAI“ įkūrėju Ilja Sutskeveriu, kuris paliko įmonę, nes nesuteikė Altmanui galimybės startuoti, ir „Anthropic“ generaliniu direktoriumi Dario Amodei, kuris yra aršūs Altmano priešai. Kaip rašo Farrow ir Marantz, net buvę „OpenAI“ valdybos nariai Altmaną laiko „nevaržomu tiesos“:

 

Vis dėlto dauguma žmonių, su kuriais kalbėjomės, pritarė Sutskeverio ir Amodei nuomonei: Altmanas turi nenumaldomą valią valdyti, kuri jį išskiria net tarp pramonininkų, kurie savo vardus deda ant erdvėlaivių. „Jo nevaržo tiesa“, – sakė valdybos narys. mums pasakė. „Jis turi dvi savybes, kurios beveik niekada nepasireiškia tame pačiame asmenyje. Pirmasis – stiprus noras įtikti žmonėms, būti mėgstamam bet kokioje sąveikoje. Antrasis – beveik sociopatiškas abejingumas pasekmėms, kurios gali kilti apgaudinėjant ką nors.“

 

Valdybos narys nebuvo vienintelis asmuo, kuris, neparagintas, pavartojo žodį „sociopatas“. Vienas iš Altmano grupės draugų pirmoje Y Combinator grupėje buvo Aaronas Swartzas, genialus, bet problemiškas programuotojas, nusižudęs 2013 m. ir dabar daugelyje technologijų sluoksnių prisimenamas kaip savotiškas išminčius. Netrukus prieš mirtį Swartzas išreiškė susirūpinimą dėl Altmano keliems draugams. „Reikia suprasti, kad Samu niekada negalima pasitikėti“, – vienam iš jų pasakė jis. „Jis yra sociopatas. Jis padarytų bet ką.“ Keletas „Microsoft“ vadovų teigė, kad nepaisant ilgalaikio Nadella lojalumo, bendrovės santykiai su Altmanu tapo įtempti. „Jis neteisingai pateikė, iškraipė, perderėjo ir sulaužė susitarimus“, – sakė vienas iš jų. Anksčiau šiais metais „OpenAI“ dar kartą patvirtino „Microsoft“ kaip išskirtinę debesijos paslaugų teikėją savo „be pilietybės“ – arba be atminties – modeliams. Tą dieną ji paskelbė apie penkiasdešimties milijardų dolerių vertės sandorį, pagal kurį „Amazon“ taps išskirtine jos įmonės platformos perpardavėja dirbtinio intelekto agentams. Nors perpardavimas yra leidžiamas, „Microsoft“ vadovai teigia, kad „OpenAI“ planas gali prieštarauti „Microsoft“ išskirtinumui. („OpenAI“ tvirtina, kad „Amazon“ sandoris nepažeis ankstesnės sutarties; „Microsoft“ atstovas teigė, kad bendrovė yra „įsitikinęs, kad „OpenAI“ supranta ir gerbia“ savo teisinius įsipareigojimus.) Vyresnysis „Microsoft“ vadovas apie Altmaną sakė: „Manau, kad yra maža, bet reali tikimybė, kad jis galiausiai bus prisimenamas kaip Bernie Madoffo arba Samo Bankmano-Friedo lygio sukčius.“

 

Farrow ir Marantz savo straipsnyje aiškina, kad Altmano sociopatinės tendencijos ne tik sukelia kitų vadovų ego sumušimą. Jo požiūris į verslą sukėlė realaus pasaulio problemų, pavyzdžiui, „ChatGPT“ paleidimas be tinkamų saugos priemonių:

 

Tuo metu, kaip rodo vidiniai pranešimai, vadovai ir valdybos nariai jau buvo įtikėję, kad Altmano nutylėjimas ir apgaulės gali turėti įtakos „OpenAI“ produktų saugumui. 2022 m. gruodžio mėn. susitikime Altmanas patikino valdybos narius, kad įvairias būsimo modelio GPT-4 funkcijas patvirtino saugos grupė. Valdybos narė ir dirbtinio intelekto politikos ekspertė Toner paprašė dokumentų. Ji sužinojo, kad labiausiai prieštaringos funkcijos – viena, leidžianti vartotojams „tiksliai suderinti“ modelį konkrečioms užduotims, ir kita, leidžianti jį naudoti kaip asmeninį asistentą – nebuvo patvirtintos. Kai valdybos narė ir verslininkė McCauley išėjo iš susitikimo, darbuotojas pasikvietė ją į šalį ir paklausė, ar ji žino apie „įsilaužimą“ Indijoje. Altmanas, per daugelį valandų trukusį instruktažą su valdyba, nesiteikė paminėti, kad „Microsoft“ išleido ankstyvąją „ChatGPT“ versiją Indijoje, neatlikusi privalomos saugos peržiūros. „Tai buvo tiesiog visiškai ignoruojama“, – tuo metu sakė Jacobas Hiltonas, „OpenAI“ tyrėjas.

 

„Breitbart News“ socialinių tinklų direktorius ir autorius Wyntonas Hallas savo akimirksniu tapusiame bestseleryje „Raudonas kodas: kairė, dešinė, Kinija ir lenktynės dėl dirbtinio intelekto kontrolės“ aiškina, kad konservatoriai turi parengti planą, kaip susidoroti su Silicio slėnio kairiųjų į dirbtinį intelektą įskiepytu šališkumu. Ypač kai asmenybės, valdančios dirbtinio intelekto įmones, yra tokios, nerimą keliančios, kaip Samas Altmanas,  reikia veiksmingo modelio, kad būtų galima pasinaudoti dirbtinio intelekto teikiama nauda be šališkumo ir trūkumų.“

 


‘Unconstrained by Truth’: Ronan Farrow’s Deep Dive into OpenAI Boss Sam Altman Reveals Sociopathic Tendencies of AI Kingpin

 

“Journalists Ronan Farrow and Andrew Marantz have published an investigation into Sam Altman, the AI kingpin behind OpenAI, revealing a troubling history of deception and sociopathic tendencies. One former OpenAI board member explains, “He has two traits that are almost never seen in the same person. The first is a strong desire to please people, to be liked in any given interaction. The second is almost a sociopathic lack of concern for the consequences that may come from deceiving someone.”

 

The New Yorker has published a major investigation of OpenAI CEO Sam Altman written by Ronan Farrow and Andrew Marantz. The article provides a fascinating and deeply researched view into the life of Altman, including blow-by-blow details of his short-lived ouster from the company.

 

The piece explains that prominent figures in the AI world hold a deep distrust of Altman, with many using the word “sociopathic” to describe his personality. Altman’s enemies list extends beyond OpenAI cofounder Ilya Sutskever, who left the company after failing to give Altman the boot, and Anthropic CEO Dario Amodei, who is bitter enemies with Altman. As Farrow and Marantz write, even former OpenAI board members see Altman as being “unconstrained by truth:”

 

    Yet most of the people we spoke to shared the judgment of Sutskever and Amodei: Altman has a relentless will to power that, even among industrialists who put their names on spaceships, sets him apart. “He’s unconstrained by truth,” the board member told us. “He has two traits that are almost never seen in the same person. The first is a strong desire to please people, to be liked in any given interaction. The second is almost a sociopathic lack of concern for the consequences that may come from deceiving someone.”

 

    The board member was not the only person who, unprompted, used the word “sociopathic.” One of Altman’s batch mates in the first Y Combinator cohort was Aaron Swartz, a brilliant but troubled coder who died by suicide in 2013 and is now remembered in many tech circles as something of a sage. Not long before his death, Swartz expressed concerns about Altman to several friends. “You need to understand that Sam can never be trusted,” he told one. “He is a sociopath. He would do anything.” Multiple senior executives at Microsoft said that, despite Nadella’s long-standing loyalty, the company’s relationship with Altman has become fraught. “He has misrepresented, distorted, renegotiated, reneged on agreements,” one said. Earlier this year, OpenAI reaffirmed Microsoft as the exclusive cloud provider for its “stateless”—or memoryless—models. That day, it announced a fifty-billion-dollar deal making Amazon the exclusive reseller of its enterprise platform for A.I. agents. While reselling is permitted, Microsoft executives argue OpenAI’s plan could collide with Microsoft’s exclusivity. (OpenAI maintains that the Amazon deal will not violate the earlier contract; a Microsoft representative said the company is “confident that OpenAI understands and respects” its legal obligations.) The senior executive at Microsoft said, of Altman, “I think there’s a small but real chance he’s eventually remembered as a Bernie Madoff- or Sam Bankman-Fried-level scammer.”

 

Farrow and Marantz explain in their article that Altman’s sociopathic tendencies don’t only result in bruised egos with other executives. His approach to business has caused real world problems, like ChatGPT launching without the proper safety guardrails in place:

 

    By then, internal messages show, executives and board members had come to believe that Altman’s omissions and deceptions might have ramifications for the safety of OpenAI’s products. In a meeting in December, 2022, Altman assured board members that a variety of features in a forthcoming model, GPT-4, had been approved by a safety panel. Toner, the board member and A.I.-policy expert, requested documentation. She learned that the most controversial features—one that allowed users to “fine-tune” the model for specific tasks, and another that deployed it as a personal assistant—had not been approved. As McCauley, the board member and entrepreneur, left the meeting, an employee pulled her aside and asked if she knew about “the breach” in India. Altman, during many hours of briefing with the board, had neglected to mention that Microsoft had released an early version of ChatGPT in India without completing a required safety review. “It just was kind of completely ignored,” Jacob Hilton, an OpenAI researcher at the time, said.

 

Breitbart News social media director and author Wynton Hall explains in his instant bestseller, Code Red: The Left, the Right, China, and the Race to Control AI, that conservatives must develop a plan to deal with the bias baked into AI by leftists in Silicon Valley. Especially when the personalities running AI companies are as troubling to learn about as Sam Altman, it takes an effective framework to gain the benefits of AI without the bias and downsides.”

 


US Vice President Vance, who visited Orban, attacked most other EU leaders: they made a huge mistake


“US Vice President J. D. Vance, during a visit to Hungary on Tuesday, accused the European Union of “foreign interference in the election.”

 

J. D. Vance praised Hungarian Prime Minister Viktor Orban as “the only visionary leader in Europe on energy security and independence.”

 

J. D. Vance was outspoken in his criticism of other EU leaders. According to him, “it is ridiculous to watch the prime ministers and leaders of some Western European capitals talking about the energy crisis, when, frankly, they should be guided by the policies that Viktor Orban is implementing in Hungary.”

 

“And if they had done that, the energy crisis we are experiencing now would not be so severe,” the US vice president said.

 

“We want Europe to succeed. We want European families to be able to afford to heat their homes and to create great things. We want Europe to be energy independent and even dominant, but it will not be energy secure if it continues to follow the failed policies of the past.

 

That is why I think Victor is a great example. He has set a course that can lead to a better, more prosperous and more energy secure Europe,” said J.D. Vance.

 

J.D. Vance also launched a tirade against “one of the most egregious examples of foreign election interference I have ever seen.” He attacked “the bureaucrats in Brussels who are trying to destroy the Hungarian economy.”

 

“They did it because they hate this guy,” said the US vice president, condemning such involvement as “shameful.”

 

Vance advised Hungarian voters to focus not on “who is for or against Europe, not who is for or against the United States, but who is for them and for all the Hungarian people.”

 

“I can tell you from my own experience that I see a guy who always fights for the interests of Hungary,” Vance said.

 

As if oblivious to the apparent contradiction in his own comments, the US vice president concluded his lengthy speech praising Orbán with the words: “One of the reasons we are here, one of the reasons the US president sent me here, is that the level of interference in the process by the bureaucrats in Brussels is disgraceful. I will not tell the Hungarian people who to vote for. I urge the bureaucrats in Brussels to do the same.”

 

J. D. Vance also hinted at what lies ahead for Ukraine: “I really think that it is in the best interest of Ukraine, Europe, Hungary and the United States to see this war end as soon as possible.”

 

According to him, the European Union “made a huge mistake” by distancing itself from oil and gas from the East.

 

“The seeds of this conflict were sown before the hostilities began, they were sown when European leaders decided to choose one specific energy economy and to distance themselves from oil and natural gas coming from the East. It was a huge mistake then, and it is clearly a huge mistake now,” he said.

 

"It's very funny to me when I hear people accuse, you know, my president of being pro-Russian. My president has done more to try to help Europe with energy and liquefied natural gas than anyone else in the world, and that weakens Russia, because we would like our allies and our friends to develop smart energy policies and their people to pay less. And if, God forbid, there is a conflict, they can count on us for energy more than anyone else," J. D. Vance emphasized.

 

J. D. Vance arrived in Hungary on Tuesday, where he was met by Foreign Minister Peter Szijjarto. His trip is seen as a support for Prime Minister V. Orban in the final stages of the election campaign, writes ELTA.

 

The US government already provided support for the election campaign of right-wing nationalist V. Orban in February. He maintains close relations with US President Donald Trump and Kremlin boss Vladimir Putin and has taken a pro-Russian stance in the Ukraine war.

 

Then US Secretary of State Marc Rubio visited Budapest, demonstratively supporting the controversial head of government.

 

“I can tell you with certainty that President Trump is very interested in your success, because your success is our success,” Rubio said during a joint press conference with Orbán.

 

Hungary will hold parliamentary elections on Sunday. Orbán’s Fidesz party, which has been in power without interruption since 2010, is trailing sharply in polls from the Tisza party of opposition politician Peter Magyar.”

 


Pas Orbaną nuvykęs JAV viceprezidentas Vance'as užsipuolė daugumą kitų Europos Sąjungos lyderių: jie padarė didžiulę klaidą

 

“JAV viceprezidentas J. D. Vance'as, antradienį lankydamasis Vengrijoje apkaltino Europos Sąjungą „užsienio kišimusi į rinkimus“.

 

J. D. Vance’as gyrė Vengrijos premjerą Viktorą Orbaną kaip esą „vienintelį įžvalgų lyderį Europoje energetinio saugumo ir nepriklausomybės klausimais“.

 

J. D. Vance’as atvirai kritikavo kitus Europos Sąjungos lyderius. Anot jo, „juokinga stebėti, kaip dalies Vakarų Europos sostinių ministrai pirmininkai ir vadovai kalba apie energetikos krizę, nors, atvirai pasakius, jie turėtų vadovautis Viktoro Orbano Vengrijoje vykdoma politika“.

 

„Ir jeigu jie būtų taip darę, dabar patiriama energetikos krizė nebūtų tokia sunki“, – pareiškė JAV viceprezidentas.

 

„Norime, kad Europai sektųsi. Norime, kad europiečių šeimos galėtų sau leisti šildymą namuose ir kurti puikius dalykus. Norime, kad Europa būtų energetiškai nepriklausoma ir netgi dominuojanti, bet ji nebus energetiškai saugi, jeigu ir toliau vadovausis nevykusia praeities politika.

 

Todėl manau, kad Viktoras yra puikus pavyzdys. Jis nubrėžė kryptį, kuri gali nuvesti į geresnę, labiau klestinčią ir energetiškai saugesnę Europą“, – kalbėjo J .D. Vance’as.

 

Taip pat nuskambėjo J. D. Vance'o tirada, nukreipta prieš „vieną iš siaubingiausių kišimosi į užsienio šalies rinkimus pavyzdžių, kokių tik esu matęs“. Jis užsipuolė „biurokratus Briuselyje, bandančius sunaikinti Vengrijos ekonomiką“.

 

„Jie tai darė, nes nekenčia šio vyruko“, – sakė JAV viceprezidentas, tokį įsitraukimą pasmerkdamas kaip „gėdingą“.

 

J. D. Vance'as Vengrijos rinkėjams patarė atkreipti dėmesį ne į tai, kas „kas už ar prieš Europą, ne kas už ar prieš JAV, bet kas už juos ir už visus Vengrijos žmones“.

 

„Iš savo patirties galiu pasakyti, kad matau vyruką, kuris visada kovoja už Vengrijos interesus“, – sakė J. D. Vance'as.

 

Tarsi nesuprasdamas akivaizdaus prieštaravimo savo paties komentaruose, savo ilgą pagyrų V. Orbanui kalbą JAV viceprezidentas užbaigė žodžiais: „Viena iš priežasčių, kodėl esame čia, viena iš priežasčių, kodėl JAV prezidentas mane čia atsiuntė, yra ta, kad tai, kiek į procesą kišasi Briuselio biurokratai, yra gėdinga. Vengrijos žmonėms nesakysiu, už ką balsuoti. Tą patį raginu padaryti ir biurokratus Briuselyje.“

 

J. D. Vance'as užsiminė ir kas toliau laukia Ukrainos: „Tikrai manau, kad tai tiek Ukraina, tiek Europa, tiek Vengrija, tiek ir JAV labiausiai suinteresuotos, kad šis karas kuo įmanoma greičiau pasibaigtų“.

 

Jo teigimu, Europos Sąjunga „padarė didžiulę klaidą“, atsiribodama nuo naftos ir dujų iš Rytų.

 

„Šio konflikto sėklos buvo pasėtos dar prieš prasidedant kariniams veiksmams, jos buvo pasėtos, kai Europos lyderiai nusprendė rinktis vieną konkrečią energetikos ekonomiką ir atsiriboti nuo iš Rytų atkeliaujančios naftos ir gamtinių dujų. Tai buvo didžiulė klaida tada, tai akivaizdžiai didžiulė klaida ir dabar“, – kalbėjo jis.

 

„Man labai juokinga, kai girdžiu žmones kaltinant, žinote, mano prezidentą dėl to, kad jis neva prorusiškas. Mano prezidentas padarė daugiau, bandydamas padėti Europai su energija ir suskystintomis gamtinėmis dujomis, nei bet kas kitas pasaulyje, ir tai silpnina Rusiją, nes norėtume, kad mūsų sąjungininkai ir mūsų bičiuliai vystytų išmanią energetikos politiką, ir jų žmonės mokėtų mažiau. O jeigu, apsaugok Dieve, koks konfliktas, jie mumis energetikos klausimu gali pasikliauti labiausiai iš visų“, – akcentavo J. D. Vance'as.

 

J.D. Vance'as antradienį atvyko į Vengriją, kur jį pasitiko užsienio reikalų ministras Peteris Szijjartas. Jo kelionė laikoma parama premjerui V. Orbanui baigiamajame rinkimų kovos etape, rašo ELTA.

 

JAV vyriausybė jau vasarį suteikė paramą dešiniojo nacionalisto V. Orbano rinkimų kampanijai. Šis palaiko artimus santykius su JAV prezidentu Donaldu Trumpu ir Kremliaus šeimininku Vladimiru Putinu ir Ukrainos kare laikosi Rusijai palankaus kurso.

 

Tada Budapešte lankėsi JAV valstybės sekretorius Marcas Rubio, demonstratyviai parėmęs ginčytiną vyriausybės vadovą.

 

„Galiu užtikrintai jums pasakyti, kad prezidentas D. Trumpas yra labai suinteresuotas jūsų sėkme, nes jūsų sėkmė yra mūsų sėkmė“, – sakė M. Rubio per bendrą spaudos konferenciją su V. Orbanu.

 

Vengrijoje sekmadienį vyks parlamento rinkimai. Nuo 2010 m. be pertrūkių valdžioje esanti V. Orbano „Fidesz“ partija apklausose smarkia atsilieka nuo opozicijos politiko Peterio Magyaro „Tisza“ partijos.”


Darbuotojai nusprendžia išeiti į pensiją, kitiems pereinant prie dirbtinio intelekto

 

„Luke'as Michelis per savo karjerą jau patyrė du technologinius pertvarkymus: pirmąjį – kompiuterinę leidybą devintajame dešimtmetyje ir vėliau – internetinę leidybą. Bet dirbtinis intelektas? Jam jau gana.

 

Taigi, kai jo darbdavys, Dana-Farber vėžio institutas, praėjusiais metais pasiūlė kai kuriems darbuotojams anksti išeiti į pensiją, 68 metų turinio strategas nusprendė paspartinti savo išėjimą. Anksčiau jis tikėjosi dirbti dar porą metų.

 

„Laikas ir energija, kurią reikia skirti visiškai naujam žodynui ir visiškai naujiems įgūdžiams išmokti, nebuvo verta“, – sakė jis.

 

Ne tai, kad jis vengia dirbtinio intelekto – jis mokosi ispanų kalbos padedamas „Anthropic“ atstovo Claude'o. Tačiau šiuo metu jis nekantrauja ištverti visus būdus, kaip technologijos žada apversti darbą aukštyn kojomis.

 

„Aš tiesiog noriu jas naudoti savo, o ne kažkieno kito tikslams“, – sakė jis.

 

Po dešimtmečių pakilimo ir tada svyravimo apie 40 % 2010-aisiais, vyresnių nei 55 metų amerikiečių, dirbančių pagal darbo jėgą, dalis sumažėjo iki 37,2 % – tai žemiausias lygis per daugiau nei 20 metų. Ekonomistai ir pensijų konsultantai teigė, kad didėjančios būsto nuosavybės ir akcijų rinkos grąžos finansinė apsauga iš dalies lemia šį nuosmukį.

 

Tačiau kai kuriems vyresnio amžiaus specialistams pinigai yra tik dalis lygties. Jie teigė, kad nenori paskutinių savo karjeros metų praleisti išgyvendami dirbtinio intelekto diegimo sumaištį, kuri atnešė naujų įrankių, naujų lūkesčių ir daug netikrumo.

 

Daugelis žmonių išeina į pensiją, kai iš karto sutrikdomi pagrindiniai jų darbo gyvenimo elementai, sakė Robertas Laura, Pensijų konsultantų asociacijos įkūrėjas ir pensijos psichologijos ekspertas.

 

„Galbūt jų autonomija yra ginčijama arba keičiama, jų draugai palieka darbovietę arba jie nesutinka su įmonės kryptimi“, – sakė jis. „Kai išryškėja du ar trys iš šių dalykų, žmonės pradeda atsisakyti.“

 

„DI yra didelis dalykas“, – sakė jis. „Jis sutrikdo jų autonomiją, jų“ profesionalumas.“

 

Michelis, kurio darbas reikalavo prižiūrėti ir kurti svetainės turinio strategiją, jau yra dirbęs šioje srityje. Kai devintajame dešimtmetyje atsirado kompiuterinė leidyba, jis buvo grafikos dizaineris, naudodamas trikampius ir guminį cementą. Interneto atsiradimas vėl viską pakeitė. Abu šie pokyčiai reikalavo naujų įgūdžių, ir jį įkvėpė mokymosi kartu su kolegomis ir bendraamžiais iššūkis.

 

Šį kartą viskas atrodė kitaip. „Jūsų baterija nebelaiko įkrovos taip ilgai, kaip anksčiau“, – sakė jis. Jis mieliau savanoriautų, kurtų meną, lankytų operas ir pirmininkautų Senėjimo tarybai Šiaurės Andoveryje, Masačusetso valstijoje, kur gyvena.

 

Praėjusią vasarą AARP atliktoje 5000 50 metų ir vyresnių žmonių apklausoje 25 % tų, kurie planavo išeiti į pensiją anksčiau nei tikėtasi, kaip veiksnius įvardijo darbo stresą ir perdegimą. Maždaug pusė išėjusiųjų į pensiją teigė, kad bent iš dalies paliko darbą dėl to, kad turėjo tam finansinį saugumą.

 

Apskritai vyresnio amžiaus amerikiečiai rečiau nei jaunesni naudojasi dirbtiniu intelektu, rodo tyrimai. Apie 30 % žmonių nuo 30 iki 49 teigė, kad darbe naudoja „ChatGPT“, tai beveik dvigubai daugiau nei 50 metų ir vyresnių asmenų dalis, rodo 2025 m. „Pew Research Center“ atlikta daugiau nei 5000 suaugusiųjų apklausa.

 

Remiantis „ManpowerGroup“ atlikta daugiau nei 13 900 darbuotojų 19 šalių apklausa, „kūdikių bumo“ karta ir X kartos atstovai taip pat patyrė didžiausią pasitikėjimo savimi, naudodamiesi dirbtinio intelekto technologijomis, sumažėjimą.

 

„Mes, kaip darbdaviai, nepakankamai gerai sakome [vyresnio amžiaus darbuotojams], kad vertiname jų jau turimus įgūdžius, taip labai, kad norime į juos investuoti, kad padėtume jums geriau atlikti savo darbą“, – sakė Becky Frankiewicz, „ManpowerGroup“ strategijos vadovė.

 

Jennifer Kerns abejonės dėl dirbtinio intelekto prisidėjo prie jos pasitraukimo praėjusį mėnesį iš „GitHub“, kur 60 metų moteris dirbo programų vadove. Ji teigė, kad kilusi iš menininkų šeimos, ją žeidžia tai, kad dirbtinio intelekto modeliai mokosi žmonių, kuriems neatlyginama už jų intelektinę nuosavybę, kūrybinio darbo. Ji taip pat nerimauja dėl dirbtinio intelekto poveikio žmonių kritinio mąstymo įgūdžiams.

 

Todėl ji nusivylė, kai „GitHub“, „Microsoft“ priklausanti programinės įrangos projektų prieglobos paslauga, pradėjo daug investuoti į dirbtinio intelekto produktus ir tikėjosi, kad darbuotojai įtrauks dirbtinį intelektą į didelę dalį savo darbo. Darbuotojų įsitraukimo apklausose įmonė pradėjo prašyti jų įvertinti savo dirbtinio intelekto naudojimą skalėje nuo 1 iki 5.

 

Kai ateidavo laikas rašyti ataskaitas ir apžvalgas, kolegos siūlydavo jai naudoti „ChatGPT“. „Aš sakydavau: „Net neįsivaizduoju, kaip tai naudoti, ir man neįdomu naudoti dirbtinį intelektą, kad ką nors parašyčiau sau“, – sakė ji.

 

Būtų buvę protingiau dirbti, kol ji priartės prie „Medicare“ tinkamumo, sakė ji. Tačiau palaukus, kol jos vaikai baigs koledžą ir bus įpirkta dalis jos akcijų dotacijų, matematika suveikė.

 

Pirmasis jos veiksmas kaip nedirbančiai asmenybei: individuali kelionė į Škotiją, kur ji dalyvavo adymo dirbtuvėse ir išmoko taisyti megztinius.

 

„DI priešingybė“, – sakė ji.

 

Darbdaviai, jau spaudžiami mažinti darbuotojų skaičių, pavyzdžiui, technologijų pramonėje, gali sveikinu kai kuriuos iš šių išėjimų į pensiją, sakė Gadas, vyriausiasis ekonomistas „Burning Glass“ institute, kuris tiria darbo rinkos duomenis.

 

„Kuo daugiau žmonių išeina į pensiją, tuo mažiau jie turi paleisti“, – sakė jis.

 

Kai kurie išmaniausi technologijų vartotojai taip pat nenori likti dirbtinio intelekto perversmo metu. Terry Grimmas, kuris IT srityje dirbo 40 metų, praėjusių metų gegužę, būdamas 65 metų, išėjo į pensiją iš vyresniojo programinės įrangos konsultanto pareigų. Jo įmonę ką tik įsigijo didesnė įmonė, o tai reiškė, kad jam teko mokytis ir integruoti patronuojančios bendrovės dirbtinį intelektą ir kitas technologines priemones į savo darbą.

 

Iki tol Grimmas tikėjosi, kad galbūt dirbs dar keletą metų, nors manė, kad tikriausiai jau turi pakankamai laiko išeiti į pensiją.

 

„Ką tik pasiekiau tašką, kai 40 valandų praleisdavau darbe, o po to 20 valandų mokydavausi ir mokiausi“, – sakė Grimmas, kuris vėliau su žmona persikėlė iš Dalaso apylinkių į gyvenamųjų namų kvartalą prie golfo aikštyno El Dorade, Arkanzaso valstijoje.

 

„Aš tada: „Leisiu jaunesniems vaikinams tai daryti.““ [1]

 

1. Workers Opt to Retire Amid Shift to AI. Weber, Lauren; Smith, Ray A.  Wall Street Journal, Eastern edition; New York, N.Y.. 07 Apr 2026: A1.